Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
USRE49353E1 · kind E1 · reissue
0Cited by
103References
48Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 20, 2020 |
| Grant date | Jan 3, 2023 |
| Priority date | — |
| Expiry date | Aug 20, 2040 |
Classification
- Technology area (CPC —)General
Abstract
Described herein are methods of treating non-metastatic castrate-resistant prostate cancer with anti-androgens.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.